Hydrogen Research Study
← Back to Research Library
Review or synthesisNarrative reviewOther or not reported

Role and mechanism of molecular hydrogen in the treatment of Parkinson’s diseases.

Fengjiao Wang, Guangjie Zhang, Qingfeng Zhai · Frontiers in neuroscience · 2025

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Cognitive Health and Neurodegeneration
Evidence type Review or synthesis
Publication type Narrative review
Hydrogen method Other or not reported

H2HUBB TAKEAWAY

This narrative review examined the available molecular-hydrogen literature. preclinical studies demonstrate promising results, clinical trials conducted thus far have yielded mixed outcomes, with some trials reporting limited or no therapeutic benefit. The reviewed evidence adds support for molecular hydrogen's therapeutic potential across the conditions, mechanisms, or outcomes examined.

What the Findings Mean

H2HUBB reviewed this publication as a synthesis of molecular-hydrogen research and summarizes the outcomes emphasized by the authors. preclinical studies demonstrate promising results, clinical trials conducted thus far have yielded mixed outcomes, with some trials reporting limited or no therapeutic benefit.

What the Researchers Studied

The authors reviewed role and mechanism of molecular hydrogen in the treatment of Parkinson's diseases.

What Effects Did Molecular Hydrogen Have?

In recent years, molecular hydrogen has been recognized for its potential neuroprotective effects, attributed to its selective antioxidant and anti-inflammatory properties. By evaluating evidence from both preclinical and clinical studies, this paper explores the potential of molecular hydrogen to attenuate oxidative stress, modulate inflammatory responses, and inhibit apoptosis in neuronal cells, while also identifying key gaps in current research. preclinical studies demonstrate promising results, clinical trials conducted thus far have yielded mixed outcomes, with some trials reporting limited or no therapeutic benefit.

Why These Findings Matter

The reviewed evidence adds support for molecular hydrogen's therapeutic potential across the conditions, mechanisms, or outcomes examined.

How Strong Is This Evidence?

This is review or synthesis evidence (narrative review).

Technical Study Details

H2HUBB classifies this publication as narrative review with review or synthesis evidence. The study used a narrative review.

Limitations and Safety

No separate limitations or safety findings were identified in the source text available to H2HUBB.

Original Study and H2HUBB Research Context

H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.